FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

419985007: Deferasirox (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2006. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2575397011 Deferasirox (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2578840016 Deferasirox en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
804201000172113 déférasirox fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Belgian module (core metadata concept)
804211000172111 deferasirox nl Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Belgian module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Deferasirox (substance) Is a Chelating agent true Inferred relationship Some
Deferasirox (substance) Is a Triazole derivative false Inferred relationship Some
Deferasirox (substance) Is a Heavy metal antagonist (substance) false Inferred relationship Some
Deferasirox (substance) Has disposition (attribute) Chelating agent (disposition) true Inferred relationship Some
Deferasirox (substance) Is a Antidote (substance) true Inferred relationship Some
Deferasirox (substance) Is a Substance with triazole structure (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing deferasirox (medicinal product) Has active ingredient True Deferasirox (substance) Inferred relationship Some 1
Product containing precisely deferasirox 125 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has active ingredient False Deferasirox (substance) Inferred relationship Some
Product containing precisely deferasirox 250 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has active ingredient False Deferasirox (substance) Inferred relationship Some
Product containing precisely deferasirox 500 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has active ingredient False Deferasirox (substance) Inferred relationship Some
Product containing deferasirox in oral dose form (medicinal product form) Has active ingredient True Deferasirox (substance) Inferred relationship Some 1
Deferasirox only product Has active ingredient True Deferasirox (substance) Inferred relationship Some 1
Deferasirox only product in oral dose form Has active ingredient True Deferasirox (substance) Inferred relationship Some 1
Product containing precisely deferasirox 500 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has basis of strength substance (attribute) True Deferasirox (substance) Inferred relationship Some 1
Product containing precisely deferasirox 500 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has precise active ingredient True Deferasirox (substance) Inferred relationship Some 1
Product containing precisely deferasirox 125 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has basis of strength substance (attribute) True Deferasirox (substance) Inferred relationship Some 1
Product containing precisely deferasirox 125 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has precise active ingredient True Deferasirox (substance) Inferred relationship Some 1
Product containing precisely deferasirox 250 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has basis of strength substance (attribute) True Deferasirox (substance) Inferred relationship Some 1
Product containing precisely deferasirox 250 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has precise active ingredient True Deferasirox (substance) Inferred relationship Some 1
Deferasirox therapy Direct substance True Deferasirox (substance) Inferred relationship Some 1
Product containing precisely deferasirox 90 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Deferasirox (substance) Inferred relationship Some 1
Product containing precisely deferasirox 90 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True Deferasirox (substance) Inferred relationship Some 1
Deferasirox 180 mg oral tablet Has precise active ingredient True Deferasirox (substance) Inferred relationship Some 1
Deferasirox 180 mg oral tablet Has basis of strength substance (attribute) True Deferasirox (substance) Inferred relationship Some 1
Deferasirox 360 mg oral tablet Has precise active ingredient True Deferasirox (substance) Inferred relationship Some 1
Deferasirox 360 mg oral tablet Has basis of strength substance (attribute) True Deferasirox (substance) Inferred relationship Some 1
Product containing precisely deferasirox 400 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has precise active ingredient True Deferasirox (substance) Inferred relationship Some 1
Product containing precisely deferasirox 400 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has basis of strength substance (attribute) True Deferasirox (substance) Inferred relationship Some 1
Product containing precisely deferasirox 100 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has precise active ingredient True Deferasirox (substance) Inferred relationship Some 1
Product containing precisely deferasirox 100 milligram/1 each tablet for conventional release oral suspension (clinical drug) Has basis of strength substance (attribute) True Deferasirox (substance) Inferred relationship Some 1

Reference Sets

Belgian subset for AllergyIntolerance, causative agent, drug

Back to Start